ENTITY
BrightGene Bio-Medical Technology

BrightGene Bio-Medical Technology (688166 CH)

24
Analysis
Health CareChina
BrightGene Bio-Medical Technology Co., Ltd. researches, develops, manufactures, and distributes biopharmaceuticals. The Company produces antifungal drugs, cardiovascular drugs, iron supplement agents, and more. BrightGene Bio-Medical Technology sells its products in Israel, USA, Japan, India, South Korea, and other countries and regions.
more
bullishSICC
25 Oct 2022 04:50

STAR50 Index Rebalance Preview: Stable Long/Short Performance in a Volatile Market

We expect the index committee to continue using a 6-month minimum listing history. That means 5 changes in December. The potential adds have...

Logo
537 Views
Share
13 Sep 2022 01:25

STAR50 Index Rebalance Preview: Four or Five Changes in December

There could be 4/5 changes if a 12/6 month minimum listing history is used. Using a 6 month minimum listing history, one-way turnover is estimated...

Logo
486 Views
Share
27 Aug 2022 09:34

STAR50 Index Rebalance: Adds Continue to Outperform as Changes Are Announced

There are 5 changes to the STAR50 in September as the index committee sticks to a 6 month minimum listing history. The adds have outperformed the...

Logo
569 Views
Share
20 Jul 2022 05:13

STAR50 Index Rebalance Preview (Sep): Adds Outperforming the Deletes

There could be 5 changes if the index committee continues using a 6 month minimum listing history. The adds have outperformed the deletes over the...

Logo
532 Views
Share
09 Jun 2022 06:11

STAR50 Index Rebalance Preview (Sep): Change Is the Only Constant

We expect the index committee to continue using a 6 month minimum listing history and that will lead to 5 changes in September. Buying the adds and...

Logo
497 Views
Share
x